Adult metachromatic leukodystrophy: case report
https://doi.org/10.14412/2074-2711-2021-2-86-90
Abstract
Metachromatic leukodystrophy (MLD) is a hereditary lysosomal storage disease inherited in an autosomal recessive pattern, which occurs across all age groups. Currently, several forms of the disease are established: late infantile (the most common), juvenile (early and late), and adult, which manifests after the age of 16 years. This case report demonstrates an adult MLD in a 24-year-old woman presented with cognitive impairment, including memory deficits, judgement, communication, and self-care skills decline. Magnetic resonance imaging findings revealed massive symmetrical periventricular white matter lesions without signs of brainstem involvement and increased lactate level. Whole exome sequencing revealed two ARSA gene mutations. Clinical and genetic characteristics of the adult MLD and modern treatment approaches are discussed.
About the Authors
T. I. Prusova
V.F. Voyno-Yasenetskiy Krasnoyarsk State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia
P. A. Reznichenko
V.F. Voyno-Yasenetskiy Krasnoyarsk State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia
K. D. Yakovleva
V.F. Voyno-Yasenetskiy Krasnoyarsk State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia
D. V. Dmitrenko
V.F. Voyno-Yasenetskiy Krasnoyarsk State Medical University, Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
1, Partisan Zheleznyak St., Krasnoyarsk 660022, Russia
References
1. Van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):261-73. doi: 10.1016/j.beem.2014.10.001. Epub 2014 Oct 16.
2. Lamichhane A, Cabrero FR. Metachromatic Leu odystrophy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021; 2020 Oct 23. PMID: 32809579.
3. Resende LL, de Paiva ARB, Kok F, et al. Adult Leukodystrophies: A Step-by-Step Diagnostic Approach. Radiographics. Jan-Feb 2019;39(1):153-168. doi: 10.1148/rg.2019180081
4. Wang Z, Lin Y, Zheng D, et al. Whole-exome sequencing identifies compound heterozygous mutations in ARSA of two siblings presented with atypical onset of metachromatic leukodystrophy from a Chinese pedigree. Clin Chim Acta. 2016 Sep 1;460:135-7. doi: 10.1016/j.cca.2016.06.038. Epub 2016 Jun 30.
5. Politi LS, Salsano E, Biffi A. Metachromatic Leukodystrophy: Too Frequent (Mis)Diagnosis? JAMA Neurol. 2018 Aug 1;75(8):1027. doi: 10.1001/jamaneurol.2018.1515
6. Saifullina EV, Magzhanov RV, Mardanova AK, et al. A clinical case of adult onset Niemann–Pick disease type C. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(3):66-70. doi: 10.14412/2074-2711-2016-3-66-70 (In Russ.).
7. Mokina TV, Zvereva AV, Pavlov YuI, et al. A clinical case of a patient with probable cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) from Chuvashia. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(3):57-61. doi: 10.14412/2074-2711-2015-3-57-61 (In Russ.).
8. Köhler W, Curiel J, Vanderver A. Adulthood leukodystrophies. Nat Rev Neurol. 2018 Feb;14(2):94-105. doi: 10.1038/nrneurol.2017.175. Epub 2018 Jan 5.
9. Elgün S, Waibel J, Kehrer C, et al. Phenotypic variation between siblings with Metachromatic Leukodystrophy. Orphanet J Rare Dis. 2019 Jun 11;14(1):136. doi: 10.1186/s13023-019-1113-6
10. Tillema J-M, Derks MGM, Pouwels PJW, et al. Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy. Ann Clin Translat Neurol. 2015 Sep;2(9):932-40. doi: 10.1002/acn3.232. Epub 2015 Aug 24.
11. Harrington M, Whalley D, Twiss J, et al. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers. Orphanet J Rare Dis. 2019 Apr 29;14(1):89. doi: 10.1186/s13023-019-1060-2
12. Van Rappard DF, de Vries ALC, Oostrom Kim J, et al. Slowly Progressive Psychiatric Symptoms: Think Metachromatic Leukodystrophy. J Am Acad Child Adolesc Psychiatry. 2018 Feb;57(2):74-6. doi: 10.1016/j.jaac.2017.11.017
13. Beerepoot Sh, Nierkens S, Boelens JJ, et al. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet J Rare Dis. 2019 Nov 4;14(1):240. doi: 10.1186/s13023-019-1220-4
14. Shaimardanova AA, Chulpanova DS, Solovyeva VV, et al. Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches. Front Med (Lausanne). 2020 Oct 20;7:576221. doi: 10.3389/fmed.2020.576221. eCollection 2020.
15. Doherty K, Barron Frazier S, Clark M, et al. A closer look at ARSA activity in a patient with metachromatic leukodystrophy. Mol Genet Metab Rep. 2019 Feb 20;19:100460. doi: 10.1016/j.ymgmr.2019.100460. eCollection 2019 Jun.
16. Hettiarachchi D, Dissanayake VHW. Correction to: Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD). BMC Res Notes. 2020 Jan 22;13(1):40. doi: 10.1186/s13104-020-4908-6
17. Hettiarachchi D, Dissanayake VHW. Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD). BMC Res Notes. 2019 Nov 6;12(1):726. doi: 10.1186/s13104-019-4773-3
18. Vanderver A. Genetic Leukoencephalopathies in Adults. Continuum (Minneap Minn). 2016 Jun;22(3):916-42. doi: 10.1212/CON.0000000000000338
19. Maia AC, da Rocha AJ, da Silva CJ, et al. Multiple cranial nerve enhancement: a new MR imaging finding in metachromatic leukodystrophy. Am J Neuroradiol. Jun-Jul 2007;28(6):999. doi: 10.3174/ajnr.A0526
20. Xu L, Zhong M, Wang Y, et al. Case Report: Novel Arylsulfatase A (ARSA) Gene Mutations in a Patient With Adult- Onset Metachromatic Leukodystrophy Misdiagnosed as Multiple Sclerosis. Front Neurol. 2021 Jan 11;11:576881. doi: 10.3389/fneur.2020.576881. eCollection 2020.
21. Wolf NI, Breur M, Plug B, et al. Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction. Ann Clin Transl Neurol. 2020 Feb;7(2):169-80. doi: 10.1002/acn3.50975. Epub 2020 Jan 22.
22. Nikitina LYu, Parfenov VA. The use of memantine in ischemic stroke. Klinicheskaya gerontologiya. 2006;(11):28-30 (In Russ.).
23. Sapronova MR, Shnayder NA, Dmitrenko DV. Prospects for gene therapy in peripheral reinnervation. Sovremennyye problemy nauki i obrazovaniya. 2016;(2):218-22 (In Russ.).
24. Clinical trial. Available from: https://clinicaltrials.gov/ct2/show/study/NCT00681811
25. Clinical trial. Available from: https://clinicaltrials.gov/ct2/show/NCT01560182
26. I Dali C, Groeschel S, Moldovan M, et al. Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1/2 study. Ann Clin Transl Neurol. 2021 Jan;8(1):66-80. doi: 10.1002/acn3.51254. Epub 2020 Dec 17.
Review
For citations:
Prusova T.I., Reznichenko P.A., Yakovleva K.D., Dmitrenko D.V. Adult metachromatic leukodystrophy: case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2):86-90. (In Russ.) https://doi.org/10.14412/2074-2711-2021-2-86-90
Views: 935
Email this article 